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Introduction {#sec1}
============

Cell size regulation is observed nearly universally among prokaryotes ([@bib23]), allowing them to both control their size at birth and homeostatically maintain it over multiple generations ([@bib54]). Cell size control and homeostasis are critical for survival: once too small, cells lack the volume required to host the essential machinery of life ([@bib36]) or initiate chromosome segregation ([@bib12]), whereas cells that are too large may suffer limitations in nutrient uptake ([@bib6]) and distribution ([@bib45]) because of their reliance on diffusive transport.

Size regulation is linked to cell cycle progression, which is marked by several key processes, including chromosome replication, segregation, and division into two daughter cells. These processes occur once per cell cycle in bacteria such as *Caulobacter crescentus* ([@bib28]), in contrast to rapidly proliferating organisms such as *Escherichia coli* ([@bib10]) and *Bacillus subtilis*, whose cells often have multi-fork replication and which can, following nutrient up-shifts, initiate replication multiple times in a single cell cycle. In *C. crescentus*, differentiation from a swarmer to a stalked cell and the initiation of chromosome replication and segregation mark the transition from cell cycle phase G1 to S. The completion of replication marks the end of S phase. Once DNA segregation is completed, cells finish cytokinesis to form sibling stalked and swarmer cells during G2/M ([@bib46]).

From the perspective of achieving a given size at birth, "size control," individual *C. crescentus* cells elongate exponentially throughout the cell cycle, as is typical for rod-shaped bacteria. Their growth is divided into an initial stage of dispersed pure elongation as peptidoglycan (PG) is inserted sporadically along the lateral walls, followed by a stage of zonal elongation and then mixed elongation and constriction in G2/M phase during which PG is inserted at mid-cell to build two new poles ([@bib1], [@bib24]). In *B. subtilis*, strains in which the cells are on average longer at the onset of constriction are also on average longer at division ([@bib50], [@bib55]). This suggests a model for cell size control, by modifying the cell length at which the divisome, the multi-protein complex that guides division, begins to generate constriction. Similarly, in *C. crescentus,* chromosome segregation must initiate before the cytokinetic Z-ring can assemble at mid-cell, coordinated by the gradient-forming FtsZ inhibitor MipZ ([@bib51]). Another possibility is that the rate of constriction is modulated; this was shown to be the case for MatP, which coordinates chromosome segregation and pole construction in *E. coli* ([@bib9]).

For a population to maintain its size over generations, "size homeostasis," different rules have been proposed. In a "sizer" model, cells require a critical size to divide; in an "adder" model, cells add a fixed volume between birth and division; and in a "timer" model, cells maintain the time between divisions. Mixed models that combine aspects of each have had success in capturing a wide range of observations ([@bib4], [@bib37]) and are often justified through their connections with specific cell cycle phases. In *E. coli*, chromosome replication from the start of the cell cycle until S/G2 may have a constant duration, underlying a timer ([@bib10]). The initiation of chromosome replication requires a fixed volume per origin of replication, and a fixed time to divide after initiation. This leads to a sizer under slow growth conditions and a phenomenological adder under fast growth, multi-origin conditions ([@bib19], [@bib53]). Putative molecular mechanisms have generally relied on the accumulation of proteins above a threshold, such as an "initiator" of unknown identity triggering replication ([@bib48]) or excess PG cell wall precursors triggering constriction ([@bib18]). A model of the latter case predicts a constant addition of volume per cell cycle, or adder. Indeed, an adder has been observed for *C. crescentus* under a wide range of growth conditions ([@bib8]). Deviations from a pure adder toward a mixed relative timer and adder have also been reported for stalked cells, observed over many generations and a range of different temperatures ([@bib4]). Any model incorporating a sizer or adder will allow smaller cells to increase, whereas larger cells to decrease in size over generations until both converge to a size set by the constant of addition ([@bib21]). Thus, both provide a clear means for a population to achieve size homeostasis.

Remarkably, although constriction makes up a significant portion of the cell cycle in many bacteria ([@bib11]), for example, up to 40% for *E. coli* ([@bib40]) or *C. crescentus* grown in minimal media ([@bib26]), its impact on cell size control and homeostasis has rarely been considered. Intriguingly, budding yeasts may use constriction rate to modulate their size in response to changes in growth conditions ([@bib27]). However, a single-cell study of the contribution of the constriction stage in bacteria has been challenging, in part due to the diffraction-limited size of the constriction site and partly due to the need for corroboration by divisome markers to unambiguously identify constriction onset. Furthermore, direct measurement of the instantaneous constriction rate has not been possible.

Here, we investigated whether and how cells adjust their constriction rate to achieve cell size control and homeostasis. We used structured illumination microscopy (SIM) ([@bib17]) to resolve the constriction site diameter and measure the size of synchronized *C. crescentus* cells as they progressed through their cell cycle. We show that perturbing the constriction rate changes cell size, independent of the elongation rate. Furthermore, we found that within a population the onset of constriction and its rate are coordinated: cells that elongate more than average before constriction undergo a more rapid constriction, leading to less elongation during constriction, and vice versa. This compensation leads to a higher fidelity adder than permitted by onset control alone, allowing *C. crescentus* to better maintain its size in the face of biological noise.

Results {#sec2}
=======

Perturbing Constriction Rate Changes the Cell Length {#sec2.1}
----------------------------------------------------

To test the role of constriction, we perturbed its rate pharmacologically and genetically. Fosfomycin (\[(2R,3S)-3-methyloxiran-2-yl\]phosphonic acid) inhibits the PG synthesis enzyme MurA ([@bib22]), which slows PG synthesis and therefore the constriction rate. In addition, the divisome includes cell wall remodeling enzymes, including the late-arriving FtsW and FtsI. Several point mutants of the glycosyltransferase FtsW ([@bib30]) and its cognate transpeptidase FtsI ([@bib2]), referred to as FtsW\*\*I\*, resulted in a gain-of-function phenotype in *C. crescentus* ([@bib31]). It was hypothesized that these mutations maintain the enzymes in their active state, and thereby would increase the constriction rate ([@bib31]).

We resolved cell shape dynamics during the cell cycle by performing dual-color imaging of the inner membrane and divisome proteins (FtsZ-GFP, FtsW-GFP) with time-lapse SIM ([Figure 1](#fig1){ref-type="fig"}A; [Videos S1](#mmc2){ref-type="supplementary-material"}, [S2](#mmc3){ref-type="supplementary-material"}, and [S3](#mmc4){ref-type="supplementary-material"}; [Transparent Methods](#mmc1){ref-type="supplementary-material"}; and Key Resource Table) on a synchronized population of cells. We used automated image analysis to quantify cell shape parameters during the cell cycle ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}, [Transparent Methods](#mmc1){ref-type="supplementary-material"}). The overall cell length relative to the wild-type (WT) strain was shorter for FtsW\*\*I\* and longer for fosfomycin-treated cells ([Figures 2](#fig2){ref-type="fig"}A, [S2](#mmc1){ref-type="supplementary-material"}A, and S2B), consistent with previous studies ([@bib18], [@bib31]).Figure 1Experimental Strategy and Constriction-Related Models for Modulation of Cell Size(A) Time-lapse SIM images: inner membrane (mCherry-MTS2, red) and FtsZ (FtsZ-GFP, green). Shown are example wild-type (WT), FtsW\*\*I\* mutant, and fosfomycin-treated cells through constriction, until separation. Images were bleach corrected for visualization, see [Transparent Methods](#mmc1){ref-type="supplementary-material"}.(B) Analysis of cell shape parameters using sDaDa (see [Transparent Methods](#mmc1){ref-type="supplementary-material"} and [Figure S1](#mmc1){ref-type="supplementary-material"}): the central line (black) is used to measure length (L), the width (W) is extracted from each perpendicular segment, and the cell contour defines cell shape (red line).(C) Constriction rate or onset control mechanisms for length. Cells are born at time 0 with length at birth L~B~ and elongate exponentially. T~C~ and L~C~ are the time and length at constriction onset. T~G~ and L~G~ are the time and length at the end of the cell cycle. Magenta parts of the cell contour represent lateral elongation, and cyan parts represent septal elongation.Scale bars: 500 nm. Bicolor bars indicate the stage: pre-constriction (magenta) and post-constriction (cyan). See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Video S1. Time-Lapse SIM Video Example of Wild-Type C. crescentus, Related to Figures 1 and 2Dual-color labeled WT strain: inner membrane (mCherry-MTS2, red), FtsZ (FtsZ-GFP, green), 15 frames per second.Video S2. Time-Lapse SIM Video Example of C. crescentus FtsW∗∗I∗ Mutant, Related to Figures 1 and 2Dual-color labeled FtsW\*\*I\* mutant strain: inner membrane (mCherry-MTS2, red), FtsZ (FtsZ-GFP, green), 15 frames per second.Video S3. Time-Lapse SIM Video Example of Fosfomycin Treated Wild-Type C. crescentus, Related to Figures 1 and 2Dual-color labeled WT strain treated with fosfomycin: inner membrane (mCherry-MTS2, red), FtsZ (FtsZ-GFP, green), 15 frames per second.

Could elongation before the onset of constriction ([Figure 1](#fig1){ref-type="fig"}C, onset modulation) set the differences in final length between FtsW\*\*I\* mutant, fosfomycin-treated, and WT cells? The appearance of a measurable constriction in SIM data corresponded well with the arrival of FtsW ([Figure S1](#mmc1){ref-type="supplementary-material"}C) and allowed us to separate elongation before and after constriction onset. Differences in elongation before constriction for all conditions ([Figure 2](#fig2){ref-type="fig"}B) were insufficient to account for the observed differences in final length ([Figure 2](#fig2){ref-type="fig"}A). Thus, we examined shape changes during constriction ([Figure 1](#fig1){ref-type="fig"}C). Individual cells continued to elongate exponentially with the same apparent rate, even as they changed from pure elongation to mid-cell remodeling and constriction ([Figures 2](#fig2){ref-type="fig"}C and 2E). However, the mean constriction rate was increased for the FtsW\*\*I\* mutant and decreased for fosfomycin-treated cells when compared with WT ([Figure 2](#fig2){ref-type="fig"}C), leading to differences in overall cell elongation during constriction ([Figure 2](#fig2){ref-type="fig"}D). We also examined the impact of MreB on cell size control using the point mutant MreBQ26P ([@bib1]), which participates only in side-wall elongation and not in septal elongation. We found that cells were longer on average than WT, with a higher elongation rate, indicating that this is a gain-of-function mutation. Interestingly, the average constriction rate increased, resulting in a nearly unchanged elongation during constriction ([Figure S2](#mmc1){ref-type="supplementary-material"}D). Thus, we have demonstrated that constriction rate modulation can be a mechanism for cell size control, independent of onset modulation ([@bib50], [@bib55]) or elongation.Figure 2Differences in Constriction Rate Yield Different Cell Sizes and Pole Shapes(A--D) Single-cell distributions of (A) length at division, (B) elongation before constriction, (C) mean constriction rate, and (D) elongation during constriction. (A--D), black bars represent the median of the population. Number of cells WT: N = 208; FtsW\*\*I\*: N = 212; FOM: N = 220. \*\*p \< 0.005, \*p \< 0.05, n.s., not significant.(E) Kymographs of representative cells, displaying cell diameter along the cell\'s length (vertical axis) versus growth time post-synchrony (horizontal axis); red indicates large diameter, blue indicates small diameter. The middle of the cell is indicated by the black horizontal line. Bicolor bars indicate the stage: pre-constriction (magenta) and post-constriction (cyan).(F) Pole shape analysis. The curvature is the reciprocal of the radius (Rc) of a circle tangent to the curve at a given point, here taken to be the pole. Each cell contour represents a representative single cell from each condition; the distribution of curvatures is plotted above (median value, black bar). ^∗^p\<0.05.(G) The pole region was extracted from each contour (\>6,000 cells per condition) and analyzed using principal component analysis (Celltool \[[@bib38]\]). Shape mode 1 mostly accounts for variation in the length of the pole; shape mode 2 mostly accounts for variation in the bluntness of the pole independent of length. The distributions of each shape mode are plotted, with examples of corresponding shapes. ^∗^p\<0.05.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

We found that individual cells continued to elongate at the same rate before and during constriction, although different perturbations modulated their constriction rate. Thus, faster constriction as in the case of FtsW\*\*I\* implies that cells should have shorter, blunter poles, whereas slower constriction as in the case of fosfomycin treatment implies that they should have longer, sharper poles. Indeed, kymographs show a more extended gradient in cell width at the poles of fosfomycin-treated cells ([Figure 2](#fig2){ref-type="fig"}E). In contrast, FtsW\*\*I\* cells show a steeper gradient at the poles. This was confirmed quantitatively by measuring the radius of curvature at the poles ([Figure 2](#fig2){ref-type="fig"}F). Furthermore, a population-wide analysis of pole shape demonstrated that over 95% of the total shape variance is accounted for with two principle shape modes, which primarily capture variation in the length and bluntness of the poles ([Figure 2](#fig2){ref-type="fig"}G). FtsW\*\*I\*, fosfomycin-treated, and WT cells were all distinct along each of these shape axes. We also observed differences in the width of the Z-ring, which appears laterally extended in the fosfomycin case ([Figure S2](#mmc1){ref-type="supplementary-material"}C). This may result from changes in length at constriction onset, since the region of lowest MipZ concentration will be more extended in longer cells ([@bib51]).

Constriction Rate Modulation Balances Elongation before and during Constriction {#sec2.2}
-------------------------------------------------------------------------------

To better decipher the relative role of the constriction rate in cell size regulation, we further analyzed its contribution to cell size homeostasis. Our experiments were designed to precisely measure the relative contributions to total elongation, and not to distinguish between different general models of homeostasis, which would require measurement over thousands of generations. We found that cells elongated with a distinct mean value for each condition ([Figure 3](#fig3){ref-type="fig"}), and that the more individual cells elongated before, the less they elongated during constriction across all conditions tested, including in *E. coli* WT cells ([Figures 3](#fig3){ref-type="fig"} and [S3](#mmc1){ref-type="supplementary-material"}). Indeed, the total elongation was independent of the relative time that the cells spent in elongation and constriction phases, with the exception of fosfomycin-treated cells ([Figure 3](#fig3){ref-type="fig"}), generally consistent with an "adder." Consequently, the variance in total elongation was lower than the variances in elongation before and during constriction would have independently suggested. This was true for all populations, including under perturbed conditions ([Figure S3](#mmc1){ref-type="supplementary-material"}A). These results demonstrate compensation, or over-compensation in the case of fosfomycin ([Figures 3](#fig3){ref-type="fig"} and [S3](#mmc1){ref-type="supplementary-material"}B), between elongation before and during constriction, resulting in a higher fidelity homeostasis for total elongation ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C).Figure 3Compensation of Elongation Before and During Constriction Contributes to Cell Size HomeostasisTotal elongation (gray) and elongation before constriction (color) for individual wild-type, FtsW\*\*I\*, and fosfomycin (FOM)-treated cells, as a function of normalized onset time (T~C~/T~G~). Lines represent the 20 cells moving average; the shaded zones represent the moving SD. Extreme outliers, more than 2 standard deviations from the mean, were omitted for the calculation of the moving average. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

What could be the mechanism for this compensation? Elongation and constriction rates together determine elongation during constriction. Compensation could occur if cells that elongate less before onset subsequently elongate more rapidly or constrict more slowly. However, elongation rate during constriction did not negatively correlate with elongation before constriction ([Figure S4](#mmc1){ref-type="supplementary-material"}A). To better understand constriction dynamics, we examined single cell waist widths as a function of relative duration of constriction ([Figure 4](#fig4){ref-type="fig"}A). Cells that elongated more before constriction also spent relatively less time constricting, indicating a higher overall constriction rate. The converse was true for cells that elongated less before constriction, but this observation alone does not rule out the possibility of a very late regulatory step being responsible for changes in average constriction rate. Single cells constricted with increasing rate until division; thus, we defined two rates, corresponding to early and late constriction ([Figure S4](#mmc1){ref-type="supplementary-material"}B), similar to [@bib4]. Interestingly, early constriction rate correlated positively with elongation before constriction, but late rate did not ([Figures 4](#fig4){ref-type="fig"}B and 4C). Hence, early constriction rate changes at the single-cell level to adjust elongation during and compensate elongation before constriction.Figure 4Early Constriction Rates Compensate for Elongation Before Onset(A) Normalized waist width as a function of normalized time during constriction, color map represents the elongation before constriction. The measurable constriction was divided into early (0.9--0.6) and late (0.6--0.3) stages.(B) Testing correlation between early constriction rate and elongation before constriction in both WT and mutant strains; WT: r = 0.45, p value \< 0.01; mutant: r = 0.24, p value \< 0.01 (Pearson correlation coefficient).(C) Testing correlation between late constriction rate and elongation before constriction; WT: r = 0.05, p value \> 0.48; mutant: r = 0.02, p value \> 0.8 (Pearson correlation coefficient).(D) Testing correlation between estimated PG precursor excess and early constriction rate, WT: r = 0.33, p value \< 0.01; mutant: r = 0.29, p value \< 0.01 (Pearson correlation coefficient). N ≥ 200 for each strain. Lines in (B--D) represent the 20-cells moving average; the shaded zones represent the moving SD. Extreme outliers, more than 2 standard deviations from the mean, were omitted for the calculation of the moving average.(E) Schematic of size regulation in *C*. *crescentus* with mixed modulation of constriction onset and rate. Magenta parts of the cell contour represent lateral elongation, and cyan parts represent septal elongation. Later onset leads to higher PG precursor excess, which drives more rapid initial constriction (dashed trajectories), and vice versa.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Although molecular mechanisms have been proposed for ensuring homeostasis, the identity of the underlying regulatory factors remains controversial. A previous model estimated PG precursor excess amount as a function of cell cycle ([@bib18]). Each cell is assumed to be born with negligible excess and generates an increasing excess of PG precursors during elongation. PG precursors are synthesized in the cell volume, at a volume-dependent rate, while being depleted as they become integrated into the cell wall (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}, Estimation of Excess Peptidoglycan Precursor). Using this model and experimentally measured cell contours to estimate the changes in surface area (Δ*A*) and volume (Δ*V*), we calculated the excess precursor area (*A*~*excess*~) at the onset of constriction (*T*~*c*~) for individual cells at the onset of constriction:$$A_{excess}\left( T_{c} \right) = \left\langle \frac{\Delta A}{\Delta V} \right\rangle_{cell\ cycle}\Delta V\left( T_{c} \right) - \Delta A\left( T_{c} \right)$$Here, 〈〉~*cell\ cycle*~ refers to the value averaged over the cell cycle. Since it took on average 30 min to set up each experiment, we underestimated the volume and area at birth, leading to an offset toward negative estimated precursor excess ([Figure 4](#fig4){ref-type="fig"}D). However, we expect the trends to be insensitive to this shift.

Discussion {#sec3}
==========

To explain our findings of constriction rate modulation dependent on elongation, we speculate on a parsimonious model in which PG precursor excess also sets the rate of PG remodeling at the constriction site, and therefore the rate of constriction: the higher the excess, the shorter the constriction duration. Indeed, we observed a positive correlation between the early rate of constriction and estimated excess PG precursor for WT and FtsW\*\*I\* cells ([Figures 4](#fig4){ref-type="fig"}D and [S4](#mmc1){ref-type="supplementary-material"}). This is also consistent with measurements of compensation in the MreBQ26P mutant, in which cells elongate faster. According to this model, an increased elongation rate with a constant PG precursor production rate implies that cells will be longer when they achieve a critical concentration to initiate constriction, without disrupting compensation. This is consistent with our findings ([Figure S3](#mmc1){ref-type="supplementary-material"}E), indicating that MreB does not play a major role in setting constriction rates. Furthermore, as the new cell poles are built, the excess PG precursor should diminish, leading to a decreased creation of area per time. This is indeed what we observe (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}, Empirical Constriction Model), consistent with models of constriction rate in *E. coli* ([@bib9]). We also observed a positive correlation between the overall rate of constriction and elongation before constriction in *E. coli* ([Figure S3](#mmc1){ref-type="supplementary-material"}F), although we were not able to independently verify early and late constriction rates. Fosfomycin inhibits PG synthesis, so we can no longer use the same mathematical expression to estimate precursor excess, since the activity of fosfomycin would introduce an extra depletion term. Interestingly, within our model, this should lead to a slower constriction, consistent with our observations ([Figure 2](#fig2){ref-type="fig"}C).

Although we have posed the regulatory factor to be PG precursors, this remains controversial because there is only indirect evidence for their role. Any "X-factor" regulatory molecule for constriction rate following the functional relationship described for surface area and volume would fit within the model we suggest. On the other hand, cells that do not elongate during the constriction phase should be insensitive to constriction rate compensation. Within the context of "size homeostasis," this proposed mechanism neither precludes nor requires any given overall model, but does suggest a means to achieve higher fidelity in adder-type models. The fact that this compensation occurs as a late step in cell cycle is consistent with the analysis of the adder, which was shown to require a regulatory step after the assembly of the Z-ring, during the constriction stage ([@bib8]).

Under nutrient-enriched growth conditions, *Salmonella, E. coli,* and *B. subtilis* can coordinate their cell size with nutrient availability, perhaps to allow sufficient room for multi-fork replication ([@bib12], [@bib41], [@bib42]) and a concomitant increase in cell size to maintain a constant volume per origin ([@bib3], [@bib59]). Remarkably, *C. crescentus* shows no such nutrient adaptation ([@bib5], [@bib8]), and how its size is modulated in the face of mutations or pharmacological perturbations has remained a mystery. Our findings show a clear contribution to cell size control from growth during the final constriction stage of the cell cycle. Modulation of constriction dynamics changes the overall length of cells, in a manner that has implications for cell shape. In the hypothetical case of extremely rapid constriction, the cell length would be set almost entirely by the growth during the pure elongation stage, leading to short cells with blunt poles. By modulating constriction onset and rate together ([Figure 4](#fig4){ref-type="fig"}E), cells may arrive at a variety of pole shapes, an emerging control mechanism for bacterial cell shape ([@bib25]).

Intriguingly, the cell wall itself can have differential properties at the division site. In *B. subtilis*, the division septum has an enrichment of pentapeptides compared with the rest of the cell envelope ([@bib35]), perhaps due to a change in the cross-linking or PG composition. In *E. coli*, glycan strands lacking stem peptides are enriched at the septum, allowing proteins containing the PG binding (SPOR) domain to be recruited ([@bib57]). In *C. crescentus,* the hydrolase DipM is recruited to the division site by its PG binding LysM domains, suggesting a distinct PG chemistry ([@bib15], [@bib33], [@bib39]). Consistently, we observed a differential, reduced staining by wheat germ agglutinin at mid-cell for later stages of the cell ([Figure S4](#mmc1){ref-type="supplementary-material"}I) ([@bib13]). We expect that in future studies it will be important to use fluorescent cell-cycle markers in conjunction with fluorescent D-amino acids ([@bib24]), which together can identify cell-cycle timing and modes of growth. It would be interesting to investigate whether the rate of constriction also affects the cell wall chemistry at the division site.

Different factors have been demonstrated to be important for determining constriction dynamics. Before cells can build a septal wall, chromosomes must be partitioned; accordingly, machinery that coordinates the two, such as MatP in *E. coli,* can also modulate constriction rate ([@bib9]). Similarly, dynamically treadmilling FtsZ filaments act as a scaffold to direct cell wall remodelers to the division site and can modulate their rate ([@bib7], [@bib25], [@bib58]). Nevertheless, the activity of PG remodeling enzymes involved in constriction might depend on PG precursor concentrations and thus may act as a part of a responsive machine. The PG remodeling enzymes FtsW and MurJ are both proposed to act as lipid II flippases ([@bib29], [@bib32]); intriguingly, in *Staphylococcus aureus,* MurJ recruitment was recently shown to coincide with a second, late constriction stage in which the constriction rate shows reduced sensitivity to chemical inhibition of FtsZ dynamics ([@bib34]). Similarly, we have shown that mutations to FtsW can increase the constriction rates in *C. crescentus*, an organism in which biphasic constriction was also reported ([@bib4]). Since, for individual cells, elongation proceeds exponentially with a single rate constant even as PG precursor excess is predicted to increase over the cell cycle, the elongation machinery is presumably relatively insensitive to changes in PG precursor amounts. By coupling the elongation machinery to the PG precursor-sensitive constriction machinery, the cell may have arrived at a simple means of compensating for fluctuations in elongation during different phases of the cell cycle. Consistent with this, others have proposed that septal and lateral PG synthesis draws precursors from the same pool, allowing communication to occur between the two processes ([@bib18], [@bib56]). This compensation still has its limitations as we observed in the case of FtsW\*\*I\* ([Figure S3](#mmc1){ref-type="supplementary-material"}B); in the case of large elongation before onset, cells must still elongate by a minimum amount during Z-ring maturation ([Figure S2](#mmc1){ref-type="supplementary-material"}C) and constriction. In the future, it will be interesting to identify the molecular partners responsible for constriction rate modulation and PG sensing, and to experimentally investigate the mechanism behind compensation of elongation.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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All data and software used to support the results of this manuscript are available from the Lead Contact upon reasonable request. Original data is available on Zenodo, DOI: [10.5281/zenodo.1248441](http://10.5281/zenodo.1248441){#interref0025} and [10.5281/zenodo.1241005](10.5281/zenodo.1241005){#interref0020}. Software is available on Zenodo, DOI: [10.5281/zenodo.1173751](10.5281/zenodo.1173751){#interref0015} and on github: <https://github.com/LEB-EPFL/sDaDa>.
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